CD163 and coinfection: It has been stated that sCD163 levels mirror the successful viral therapy displaying a significant decrease after treatment; however, sCD163 values do not fully normalize post-ART or post–HCV DAA therapy which may reflect the cooperative force of HIV and HCV to elevate sCD163, as a consequence of the interactive and additive effects in HIV/HCV coinfection [22, 32–36].